Work

Employment History of Morgan Schapiro

Ionis Pharmaceuticals, Inc.

Director Business Development & Head of External Innovation

Sebela Pharmaceuticals Inc.

Associate Director of Business Development

Bausch Health Companies Inc.

Senior Business Development Analyst

Thomson Reuters

Equities Strategy and Business Development Analyst

Leverage Academy, LLC

Teaching Fellow

Ionis Pharmaceuticals

Executive Director, Business Development

BU Advanced Topic Debate Club

Market Realist

Emerging Market Analyst

Pi Kappa Alpha Fraternity

Schools

Schools Attended by Morgan Schapiro

  • Questrom School of Business, Boston University
  • Imperial College London
  • Boston University - School of Management
  • Friends Academy, Long Island NY
  • Boston University

Related

Others that have worked at the same companies

Territory Business Manager at valeant.com
Territory Manager at valeant.com
Director Talent Acquisition at valeant.com

Vice President at Bank of America at optonline.net
Counsel at Davidoff Hutcher and Citron LLP at optonline.net

Legislative Director at bu.edu
Hospital and Response Data Coordinator at bu.edu
Project Manager, Scenes at bu.edu

Frequently Asked Questions

Morgan Schapiro is a Director Business Development & Head of External Innovation at Ionis Pharmaceuticals, Inc. located in San Diego County, California, United States.

Morgan Schapiro works as a Director Business Development & Head of External Innovation at Ionis Pharmaceuticals, Inc..

Morgan Schapiro is located in San Diego County, California, United States.

Morgan Schapiro attended Questrom School of Business, Boston University, Imperial College London, Boston University - School of Management, Friends Academy, Long Island NY, Boston University.

Morgan Schapiro has worked with colleagues at various companies. You can see some of their coworkers listed above who have worked at the same organizations.

You can send Morgan Schapiro a message using the contact form on this page, or click "Show Contact Info" to view additional contact details.